시린지 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2024-2032년)

The Global Syringes Market was valued at USD 19.6 billion in 2023, with projections indicating a 10.9% CAGR from 2024 to 2032. Syringes, vital medical devices for fluid injection and withdrawal, consist of a barrel, plunger, and needle or nozzle for precise fluid control.

Growth in this market is driven by an aging population and an increase in chronic health conditions, which elevate the demand for safe, reliable injection devices. Additionally, the rise in home healthcare adoption supports syringe use as patients seek more convenient and affordable treatment solutions beyond clinical settings.

The market is segmented by preparation into ready-to-use (RTU) and ready-to-sterilize (RTS) syringes. The RTU segment leads the market, with an anticipated 11.1% CAGR, owing to its convenience for healthcare providers and patients. Often prefilled with medication, RTU syringes simplify administration, minimize dosage errors, and reduce contamination risk. Their design promotes compliance, particularly in chronic disease management, and is increasingly favored in home healthcare due to the ease of self-administration.

By application, the market is categorized into small molecules, diagnostics, and biologics, with biologics holding a 54.7% share in 2023. This segment's strength stems from the growing demand for biologic drugs targeting chronic and autoimmune conditions, which require precise delivery methods. The shift toward personalized medicine further underscores the need for efficient delivery systems, solidifying biologics' market dominance.

In North America, the U.S. leads with a CAGR of 10.6%, driven by advanced healthcare infrastructure, strong R&D efforts, and high demand for medical devices. The U.S. focus on innovation has produced advanced syringe technologies, including safety-engineered and prefilled options that enhance patient safety and treatment effectiveness. Rising chronic diseases and vaccination initiatives further stimulate market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising chronic diseases and geriatric population
    • 3.2.1.2 Increasing vaccination initiatives
    • 3.2.1.3 Growing technology advancement focusing on patient safety
    • 3.2.1.4 Rise in biologics and biosimilars research activities
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High risk of needlestick injuries
    • 3.2.2.2 Stringent regulatory requirements
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Preparation, 2021 - 2032 ($ Mn and Units)

• 5.1 Key trends
• 5.2 Ready to use (RTU)
• 5.3 Ready to sterilize (RTS)

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn and Units)

• 6.1 Key trends
• 6.2 Small molecules
• 6.3 Biologics
• 6.4 Diagnostics

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn and Units)

• 7.1 Key trends
• 7.2 Glass
• 7.3 Plastic/ polymers

Chapter 8 Market Estimates and Forecast, By Size, 2021 - 2032 ($ Mn and Units)

• 8.1 Key trends
• 8.2 <1 ml
• 8.3 1 ml - 2 ml
• 8.4 3 ml - 5 ml
• 8.5 6 ml - 10 ml
• 8.6 10 - 20 ml
• 8.7 20 - 30 ml
• 8.8 >30 ml

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn and Units)

• 9.1 Key trends
• 9.2 Hospitals & clinics
• 9.3 Pharma & biotech companies
• 9.4 Contract development and manufacturing organizations (CDMOs)
• 9.5 Diagnostic laboratories
• 9.6 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn and Units)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Italy
  • 10.3.5 Spain
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 Becton, Dickinson and Company (BD)
• 11.2 Cardinal Health
• 11.3 Corning
• 11.4 Daikyo Seiko
• 11.5 DWK Life Sciences
• 11.6 Gerresheimer AG
• 11.7 ICU Medical
• 11.8 Mitsubishi Gas Chemical Company
• 11.9 Nipro
• 11.10 SCHOTT Pharma (SCHOTT Group)
• 11.11 Shandong Province Medicinal Glass
• 11.12 SHIOTANI GLASS
• 11.13 Terumo
• 11.14 Weigao Group
• 11.15 West Pharmaceutical Services